Discover 1,576 paid clinical trials in Jersey City, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,576
The ArtixASCEND Study
for
Acute Lower Limb Arterial Occlusion
Location: Brooklyn NY, New York NY, Stony Brook NY,
Sponsor: Inari Medical
Sex: All
Age: 18+
Code: NCT07135895
Recruiting
STRIDE Biorepository
for
Anemia, Sickle Cell
Location: Brooklyn NY, New York NY, Newark NJ, Hackensack NJ,
Sponsor: Emory University
Sex: All
Age: 15 - 40
Code: NCT02843347
Recruiting
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Location: New York NY, New Brunswick NJ, Hawthorne NY,
Sponsor: BiomX Ltd
Sex: All
Age: 18+
Code: NCT06998043
Phase 2, Recruiting
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
for
Lung Non-Small Cell Carcinoma
Location: New York NY, Rego Park NY, Lake Success NY, Red Bank NJ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07388524
Phase 3, Recruiting
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
for
Pancreatic Neoplasm
Location: New York NY, Englewood NJ, The Bronx NY, Summit NJ,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 50 - 70+
Code: NCT04239573
Recruiting
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
for
Head and Neck Squamous Cell Carcinoma,
Location: New York NY, Rego Park NY, Forest Hills NY,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06992427
Phase 3, Recruiting
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Location: New York NY, Teaneck NJ, Brentwood NY, Toms River NJ,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 50 - 70+
Code: NCT06541704
Phase 3, Recruiting
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
for
Renal Cell Carcinoma (RCC),
Location: New York NY, Hackensack NJ, East Brunswick NJ,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT05176483
Phase 1, Recruiting
Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).
for
Higher-risk Myelodysplastic Syndrome
Location: New York NY, Hackensack NJ, The Bronx NY, Baltimore MD,
Sponsor: Ascentage Pharma Group Inc.
Sex: All
Age: 18+
Code: NCT06641414
Phase 3, Recruiting
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Location: New York NY, Hackensack NJ, Stony Brook NY,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT06679101
Phase 3, Recruiting
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
for
Metastatic Castration Sensitive Prostate Cancer (mCSPC),
Location: New York NY, Long Island City NY, The Bronx NY,